Get started
Author

L Zhang

Observed names: L. Zhang, Linghua Harris Zhang, Lucie Zhang
ORCID: 0000-0002-7441-3321
Observed ORCID: 0000-0002-7441-3321
OpenAlex ID: A5035829366
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
2017 · H. Nokihara, S. Lu, et al. · Annals of Oncology · 99
Corrigendum to ‘Consensus for HER2 Alterations Testing in Non-small Cell Lung Cancer’
2022 · S. Ren, J. Wang, et al. · ESMO Open · 6
[Atezolizumab therapy in Chinese patients with locally advanced or metastatic solid tumors: An open-label, phase Ⅰ study].
2022 · L Zhang, J F Gong, et al. · PubMed · 4
NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune response, and the HIF-1α hypoxia pathway to promote healing in viral-induced lung injury
2024 · Cymbeline Culiat, Dharmendra Soni, et al. · Biochemical and Biophysical Research Communications · 3
PDF
ENCORE: Updated efficacy and safety data from the global phase III ALEX study of alectinib (ALC) vs. crizotinib (CZ) in untreated advanced ALK+ NSCLC
2019 · M Thomas, DR Camidge, et al. · Pneumologie · 3
Validation and cross-cultural insights of the French translation of the Severe Asthma Questionnaire
2025 · Lucie Zhang, Charles Bokobza, et al. · ERJ Open Research · 2
Abstract OT1-01-04: Phase 1 study of D-0502, an orally bioavailable SERD with optimized pharmacological and PK/PD property for ER-positive breast cancer
2019 · L Zhang, D Dai, et al. · Cancer Research · 1
[Investigation on status of lung cancer cough management and concept and practice of lung cancer cough management in Chinese medical providers].
2021 · S X Luo, G X Lai, et al. · PubMed
Works count: 8
Citation count: 118
H-index: 3
I10-index: 1
Year
Topic
Type